Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Suzuki, Satoko ^a,b   Kodera, Yoshio ^b   Saito, Tatsuya ^a,b   Fujimoto, Kazumi ^a   Momozono, Akari ^a,b   Hayashi, Akinori ^a   Kamata, Yuji ^a   Shichiri, Masayoshi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; METHIONINE; METHIONINE SULFOXIDE; PLASMA PROTEIN; SERUM ALBUMIN;

ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; HUMAN; MASS SPECTROMETRY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

BIOMARKERS; BLOOD PROTEINS; HUMANS; MASS SPECTROMETRY; METHIONINE; OXIDATION-REDUCTION; OXIDATIVE STRESS; SERUM ALBUMIN;

EID: 85003545066     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38299     Document Type: Article

References (48)

1. Shringarpure, R., Davies, K. J. Protein turnover by the proteasome in aging and disease. Free Radic. Biol. Med. 32, 1084-1089(2002).
2. Ruan, H., et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA 99,2748-2753 (2002).
3. Gorrini, C., Harris, I. S., Mak, T. W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12, 931-947(2013).
4. Pitocco, D., Tesauro, M., Alessandro, R., Ghirlanda, G., Cardillo, C. Oxidative stress in diabetes: implications for vascular and othercomplications. Int. J. Mol. Sci. 14, 21525-21550 (2013).
5. Swomley, A. M., Butterfield, D. A. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from humandata provided by redox proteomics. Arch. Toxicol. 89, 1669-1680 (2015).
6. Drummond, G. R., Selemidis, S., Griendling, K. K., Sobey, C. G. Combating oxidative stress in vascular disease: NADPH oxidasesas therapeutic targets. Nat. Rev. Drug Discov. 10, 453-471 (2011).
7. Ho, E., Karimi Galougahi, K., Liu, C. C., Bhindi, R., Figtree, G. A. Biological markers of oxidative stress: Applications tocardiovascular research and practice. Redox Biol. 1, 483-491 (2013).
8. Vogt, W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol. Med. 18, 93-105 (1995).
9. Clement-Jones, V., Lowry, P. J., Rees, L. H., Besser, G. M. Met-enkephalin circulates in human plasma. Nature 283, 295-297 (1980).
10. Lee, B. C., Dikiy, A., Kim, H. Y., Gladyshev, V. N. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim. Biophys. Acta 1790, 1471-1477 (2009).
11. Kim, H. Y., Gladyshev, V. N. Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair inmammals. Biochem. J. 407, 321-329 (2007).
12. Griffiths, S. W., Cooney, C. L. Relationship between protein structure and methionine oxidation in recombinant human alpha1-antitrypsin. Biochemistry 41, 6245-6252 (2002).
13. Yin, D., Kuczera, K., Squier, T. C. The sensitivity of carboxyl-terminal methionines in calmodulin isoforms to oxidation by H(2)O(2) modulates the ability to activate the plasma membrane Ca-ATPase. Chem. Res. Toxicol. 13, 103-110 (2000).
14. Aledo, J. C., Canton, F. R., Veredas, F. J. Sulphur atoms from methionines interacting with aromatic residues are less prone tooxidation. Sci. Rep. 5, 16955 (2015).
15. Ghesquiere, B., et al. Redox proteomics of protein-bound methionine oxidation. Mol. Cell Proteomics 10, M110-006866 (2011).
16. Hardin, S. C., Larue, C. T., Oh, M. H., Jain, V., Huber, S. C. Coupling oxidative signals to protein phosphorylation via methionineoxidation in Arabidopsis. Biochem J 422, 305-312 (2009).
17. Brock, J. W., et al. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J. Lipid Res. 49, 847-855 (2008).
18. Schoneich, C. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim. Biophys. Acta 1703, 111-119 (2005).
19. Glaser, C. B., Yamin, G., Uversky, V. N., Fink, A. L. Methionine oxidation, alpha-synuclein and Parkinson's disease. Biochim. Biophys. Acta 1703, 157-169 (2005).
20. Saito, T., et al. Establishment and application of a high-quality comparative analysis strategy for the discovery and small-scalevalidation of low-abundance biomarker peptides in serum based on an optimized novel peptide extraction method. J. Electrophoresis57, 1-9 (2013).
21. Kawashima, Y., et al. Enhanced recovery of lyophilized peptides in shotgun proteomics by using an LC-ESI-MS compatiblesurfactant. Proteomics 13, 751-755 (2013).
22. Kawashima, Y., et al. Cyclic sample pooling using two-dimensional liquid chromatography system enhances coverage in shotgunproteomics. Biomed. Chromatogr. 27, 691-694 (2013).
23. Kawashima, Y., et al. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serumsamples. J. Proteome Res. 9, 1694-1705 (2010).
24. Monnier, L., Colette, C. Glycemic variability: should we and can we prevent it? Diabetes Care 31, S150-154 (2008).
25. Ogawa, A., et al. New indices for predicting glycaemic variability. PLoS One 7, e46517 (2012).
26. Zhang, X. H., Weissbach, H. Origin and evolution of the protein-repairing enzymes methionine sulphoxide reductases. Biol. Rev. Camb. Philos. Soc. 83, 249-257 (2008).
27. Weissbach, H., Resnick, L., Brot, N. Methionine sulfoxide reductases: history and cellular role in protecting against oxidativedamage. Biochim. Biophys. Acta 1703, 203-212 (2005).
28. Ezraty, B., Aussel, L., Barras, F. Methionine sulfoxide reductases in prokaryotes. Biochim. Biophys. Acta 1703, 221-229 (2005).
29. Davies, M. J. The oxidative environment and protein damage. Biochim. Biophys. Acta 1703, 93-109 (2005).
30. Nielsen, H. K., Loliger, J., Hurrell, R. F. Reactions of proteins with oxidizing lipids. 1. Analytical measurements of lipid oxidationand of amino acid losses in a whey protein-methyl linolenate model system. Br. J. Nutr. 53, 61-73 (1985).
31. Savige, W. E., Fontana, A. Interconversion of methionine and methionine sulfoxide. Methods Enzymol. 47, 453-459 (1977).
32. Glaser, C. B., et al. Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats. Am. Rev. Respir. Dis. 136,857-861 (1987).
33. Masuda, T., Tomita, M., Ishihama, Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J. Proteome Res. 7, 731-740 (2008).
34. Nishikawa, T., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature404, 787-790 (2000).
35. Jay, D., Hitomi, H., Griendling, K. K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 40,183-192 (2006).
36. Yorek, M. A. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 37, 471-480 (2003).
37. Baynes, J. W., Thorpe, S. R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48,1-9 (1999).
38. Fort, J. Chronic renal failure: a cardiovascular risk factor. Kidney Int. 99, S25-29 (2005).
39. Fortuno, A., et al. Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production inpatients with early chronic kidney disease. Kidney Int. 68. S71-75 (2005).
40. Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., Wouters, E. F. Systemic effects of smoking. Chest 131,1557-1566 (2007).
41. Faux, S. P., et al. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14,S90-96 (2009).
42. U. S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the SurgeonGeneral 2014, Centers for Disease Control and Prevention, Rockville, MD.
43. Chida, S., et al. Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study. Sci. Rep. 6, 26380 (2016).
44. Shichiri, M., Nishio, Y., Ogura, M., Suenaga, M., Marumo, F. Effects of dietary protein restriction on hemodynamics in chronicrenal failure. Kidney Int. 43, 443-447 (1993).
45. Shichiri, M., Nishio, Y., Ogura, M., Marumo, F. Effect of low-protein, very-low-phosphorus diet on diabetic renal insufficiencywith proteinuria. Am. J. Kidney Dis. 18, 26-32 (1991).
46. Hayashi, A., et al. Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis. J. Diabetes Complications 30, 1494-1499 (2016).
47. Ogawa, A., et al. Physiological fluctuations of human plasma total salusin-?, an endogenous parasympathomimetic/proatherosclerotic peptide. Peptides 59, 83-88 (2014).
48. Kamata, Y., et al. Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetesmellitus. J Diabetes Complications, doi: S1056-8727(16)30252-5/j. jdiacomp. 2016. 06. 023 (2016).